Annual Report

Overview

The report describes the company's acquisition of Genesis I.B.R.C. Private Limited, which became a wholly owned subsidiary, and the subsidiary's acquisition of Genesis Biosciences IBRC. It highlights diversification into biotechnology and probiotic products. Consolidated revenue from operations was INR 43,319,123, while paid-up equity capital increased from Rs.10 Crores to Rs.13 Crores through a preferential issue. Corporate governance disclosures cover a five-member board and three board committees.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2017-2018
Period: 1 April 2017 – 31 March 2018
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services